Ayman Shehata Dawood*

Assistant Professor of Obstetrics and Gynecology, Tanta University, Tanta, Egypt

*Corresponding Author: Ayman Shehata Dawood, Assistant Professor of Obstetrics and Gynecology, Tanta University, Tanta, Egypt

Received: September 18, 2025; Published: September 30, 2025

Abstract

Placenta accrerta spectrum comprises a group of disorders that are considered a nightmare for both patients and obstetricians. PAS is associated with catastrophic complications and mortality rates. The main treatment is cesarean hysterectomy; however, some obstacles exist in performing this procedure. Patient age, desire for future fertility, and psychological aspects are the main obstacles in the decision-making process. Conservative treatment is not an easy road with roses on its sides; it is associated with many challenges and risks. In this review, we discuss the challenges and risks associated with conservative treatment of PAS.

Keywords: PAS; Placenta; Cesarean Section; Challenges; Hysterectomy

References

1. Eric RM., et al. “Placenta accreta spectrum”. In Gabbe's Obstetrics: Normal and Problem Pregnancies, 8th ed. Elsevier Health Sciences 21 (2020): 408-420.
2. Chen CP., et al. “Extracellular matrix induces trophoblast HtrA4 expression: Implications for the pathogenesis of placenta accreta spectrum”. Placenta (2025).
3. Afshar Y., et al. “Biology and pathophysiology of placenta accreta spectrum disorder”. Obstetrics and Gynecology6 (2025): 611-620.
4. Jauniaux E., et al. “Epidemiology of placenta previa accreta: a systematic review and meta-analysis”. BMJ open11 (2019): e031193.
5. Carusi DA. “The placenta accreta spectrum: epidemiology and risk factors”. Clinical Obstetrics and Gynecology4 (2018): 733-42.
6. Kayem G., et al. “Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and placenta previa or low-lying: a prospective population-based study”. Scientific Reports1 (2024): 6564.
7. Adkins E and Gatta LA. “Clinical Risk Factors for Placenta Accreta Spectrum”. Topics in Obstetrics and Gynecology5 (2025): 1-5.
8. Marshall NE., et al. “Impact of multiple cesarean deliveries on maternal morbidity: a systematic review”. American Journal of Obstetrics and Gynecology 205 (2011): 262.e1-8.
9. Maged AM., et al. “Diagnostic accuracy of ultrasound in diagnosing placenta accreta spectrum: a systematic review and meta-analysis”. BMC Pregnancy and Childbirth 1 (2023): 354.
10. Zhang J., et al. “Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum”. BMC Pregnancy and Childbirth1 (2023): 569.
11. D'Antonio F., et al. “Prenatal identification of invasive placentation using ultrasound: a systematic review and meta-analysis”. Ultrasound Obstetrics and Gynecology 42 (2013): 509-517.
12. Chen Q., et al. “Advances in prenatal diagnosis of placenta Accreta Spectrum”. Medicina3 (2023): 392.
13. Jauniaux E., et al. “The role of transvaginal ultrasound in the third-trimester evaluation of patients at high risk of placenta accreta spectrum at birth”. American Journal of Obstetrics and Gynecology4 (2023): 445-e1.
14. Kapoor H., et al. “Review of MRI imaging for placenta accreta spectrum: pathophysiologic insights, imaging signs, and recent developments”. Placenta 104 (2021): 31-39.
15. Jauniaux E., et al. “FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. International Journal of Gynecology and Obstetrics1 (2019): 20-24.
16. Cali G., et al. “Prenatal ultrasound staging system for placenta accreta spectrum disorders”. Ultrasound Gynecology and Obstetrics6 (2019): 752-760.
17. Jauniaux E., et al. “Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging”. American Journal of Obstetrics and Gynecology1 (2018): 75-87.
18. Cali G., et al. “Value of first‐trimester ultrasound in prediction of third‐trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome”. Ultrasound Obstetrics and Gynecology4 (2020): 450-459.
19. Dar PE and Doulaveris G. “First-trimester screening for placenta accreta spectrum”. American Journal of Obstetrics and Gynecology MFM5 (2024): 101329.
20. Maurea S., et al. “Prediction of placenta accreta spectrum in patients with placenta previa using a clinical, US and MRI combined model: a retrospective study with external validation”. European Journal of Radiology 168 (2023): 111116.
21. Greenberg VR., et al. “Ultrasound prediction of placenta accreta spectrum disorders”. American Journal of Obstetrics and Gynecology1 (2022): S585.
22. Eid MM. “The diagnostic accuracy of ultrasound in predicting placenta accreta spectrum (PAS)”. The Egyptian Journal of Fertility and Sterility2 (2022): 29-39.
23. Zheng W., et al. “Validation of a scoring system for predicting obstetric complications in the placenta accreta spectrum disorder”. Journal of Maternal-Fetal and Neonatal Medicine21 (2022): 4149-4155.
24. Luo L., et al. “Scoring system for the prediction of the severity of placenta accrete spectrum in women with placenta previa: a prospective observational study”. Archives of Gynecology and Obstetrics 300 (2019): 783-791.
25. Abd-Elrouf DM., et al. “Scoring System for the Prediction of the Severity of Placenta Accreta Spectrum (PAS) in Women with Placenta Previa (PAS scoring system)”. The Egyptian Journal of Fertility and Sterility 2 (2025): 63-74.
26. Quiner T., et al. “107: First trimester ultrasound scoring systems poorly predict placenta accreta spectrum”. American Journal of Obstetrics and Gynecology 222 (2020): S86.
27. Shazly SA., et al. “Prediction of clinical outcomes in women with placenta accreta spectrum using machine learning models: an international multicenter study”. Journal of Maternal-Fetal and Neonatal Medicine25 (2025): 6644-6653.
28. Taşkum İ., et al. “Predicting the risk of cesarean hysterectomy in the management of placenta accreta spectrum disorders: a new model based on clinical findings and ultrasonography”. Archives of Gynecology and Obstetrics1 (2025): 55-66.
29. Elbasuiny HR., et al. “Early Prediction of Placenta Accreta Spectrum Using Different Modalities: An Evidence-Based Analysis”. Clinical and Experimental Obstetrics and Gynecology1 (2024): 27.
30. Chong Y., et al. “Ultrasonic scoring system to predict the prognosis of placenta accreta: a prospective cohort study”. Medicine 35 (2018): e12111.
31. Reale SC and Farber MK. “Management of patients with suspected placenta accreta spectrum disorder”. BJA Education2 (2022): 43-51.
32. Reale SC and Farber MK. “Management of patients with suspected placenta accreta spectrum disorder”. BJA Education2 (2022): 43-51.
33. Alwatban S., et al. “Anesthetic Management of Placenta Accreta Spectrum Disorders: A Narrative Review”. Journal of Obstetric Anesthesia and Critical Care1 (2025): 12-22.
34. Rath SK., et al. “A Review of Conservative Surgical Approaches for Managing the Placenta Accreta Spectrum”. Cureus3 (2025).
35. Jauniaux E., et al. “Placenta accreta spectrum”. Nature Reviews Disease Primers1 (2025): 1-8.
36. Abousifein M., et al. “Addressing the diagnosis, management, and complication challenges in placenta accreta spectrum disorder: a descriptive study”. Journal Clinical Medicine11 (2024): 3155.
37. Einerson BD., et al. “Society for Maternal-Fetal Medicine Special Statement: Emergency checklist, planning worksheet, and system preparedness bundle for placenta accreta spectrum”. American Journal of Obstetrics and Gynecology1 (2024): B2-11.
38. Rosenthal EA., et al. “Placenta Accreta Spectrum Outcomes with a Multidisciplinary Team and Standardized Ultrasound Approach”. American Journal of Perinatology (2025).
39. Nieto-Calvache AJ., et al. “Management of placenta accreta spectrum in low-and middle-income countries”. Best Practice & Research: Clinical Obstetrics & Gynecology 94 (2024): 102475.
40. Stafford IA., et al. “Etiology and Management of Hemorrhage (Including Accreta)”. Critical Care in Obstetrics (2024): 627-663.
41. Hessami K., et al. “Conservative management of the placenta accreta spectrum is associated with improved surgical outcomes compared to cesarean hysterectomy: a systematic review and meta-analysis”. American Journal of Obstetrics and Gynecology (2025).
42. Shepherd AM and Mahdy H. “Placenta Accreta [Updated September 26, 2022]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing (2025).
43. Zulfiqar Y. “Placenta Percreta With Bladder Involvement”. Journal of Midwifery1 (2024): 72-74.
44. Khan FS., et al. “Correlation of Placenta Accreta Index with Maternal Outcomes in Patients with Morbidly Adherent Placenta”. Pakistan Armed Forces Medical Journal6 (2024): 1593.
45. Muñoz M., et al. “Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement”. Blood Transfusion2 (2019): 112-136.
46. Hage L., et al. “Identifying risk factors for urologic complications in placenta accreta spectrum surgical management”. World Journal of Urology1 (2024): 539.
47. Rath SK., et al. “A Review of Conservative Surgical Approaches for Managing the Placenta Accreta Spectrum”. Cureus3 (2025).
48. Mojahed E., et al. “Outcomes of Conservative Management for Decreasing Blood Loss in Cases Placenta Accreta Spectrum Disorders (PAS): A Meta-Analysis and Systematic Review”. Evidence Based Women's Health Journal15 (2025): 1-9.
49. Shamshirsaz AA., et al. “Coagulopathy in surgical management of placenta accreta spectrum”. European Journal of Obstetrics and Gynecology and Reproductive Biology 237 (2019): 126-130.
50. Biele C., et al. “Conservative management of abnormally invasive placenta complicated by local hyperfibrinolysis and beginning disseminated intravascular coagulation”. Archives of Gynecology and Obstetrics 303 (2021): 61-68.
51. Abi Habib P., et al. “Placenta accreta spectrum conservative management and coagulopathy: case series and systematic review”. Ultrasound Obstetrics and Gynecology 6 (2024): 731-737.
52. Sharma B., et al. “Peripartum hysterectomy in a tertiary care hospital: Epidemiology and outcomes”. Journal of Anaesthesiology Clinical Pharmacology3 (2017): 324-328.
53. Mojahed E., et al. “Outcomes of Conservative Management for Decreasing Blood Loss in Cases Placenta Accreta Spectrum Disorders (PAS): A Meta-Analysis and Systematic Review”. Evidence Based Women's Health Journal15 (2025): 1-9.
54. Wijesinghe V., et al. “Quality of surgical management of placenta accreta spectrum in a tertiary center in Sri Lanka: baseline study for quality improvement project: problems and solutions”. BMC Pregnancy and Childbirth 1 (2022): 509.
55. Srinivasan B., et al. “Study on outcomes of pregnancy in women with Placenta Accreta Spectrum: a 10-year study in a Tertiary Care Center”. Journal of South Asian Federation of Obstetrics and Gynaecology3 (2021): 94-97.
56. Lawrence ER., et al. “Maternal Mortality in Low and Middle-Income Countries”. Obstetrics and Gynecology Clinics of North America4 (2022): 713-733.
57. Souza JP., et al. “A global analysis of the determinants of maternal health and transitions in maternal mortality”. The Lancet Global Health2 (2024): e306-316.
58. Ayalde J., et al. “A review of placenta accreta spectrum and its outcomes for perinatal mental health”. Australasian Psychiatry1 (2023): 73-75.
59. Salama K., et al. “Mental Health and Placenta Accreta Spectrum”. American Journal of Perinatology9 (2023): 1009-1012.
60. Matsubara S. “Psychological burden of women with placenta accreta spectrum: some specific features. Acta Obstetricia et Gynecologica Scandinavica9 (2023): 1243-1244.
61. Michelet D., et al. “Emergency hysterectomy for life-threatening postpartum haemorrhage: risk factors and psychological impact”. Gynécologie Obstétrique Fertilité 43 (2015): 773–779.
62. Sentilhes L., et al. “Management of placenta accreta”. Acta Obstetricia et Gynecologica Scandinavica 92 (2013): 1125–1134.
63. Grönvall M., et al. “Is there an association between postpartum hemorrhage, interventional radiology procedures, and psychological sequelae?” Journal of Maternal-Fetal and Neonatal Medicine 34 (2021): 1792-1796.
64. Chen K., et al. “Subsequent pregnancy outcomes following conservative management for placenta accreta spectrum disorders: an ambispective cohort study”. Journal of Maternal-Fetal and Neonatal Medicine 1 (2025): 2477782.

Citation

Citation: Ayman Shehata Dawood. “Challenges and Risks Facing Conservative Management of Placenta Accreta Spectrum in Low Resources Countries". Acta Scientific Women's Health 7.10 (2025): 32-42.

Copyright

Copyright: © 2025 Ayman Shehata Dawood. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.